VERTEX PHARMACEUTICALS INC / MA
SEC 4 · Filed
0000875320-26-000090Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Feb 17, 2026
Payment of exercise price or tax by delivery of securities by Kewalramani Reshma
- Security
- Common Stock
- Shares
-
6,554
- Price per share
-
483.75
Structured facts
{
"code": "F",
"date": "2026-02-17",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {},
"owners": [
{
"cik": "0001735944",
"name": "Kewalramani Reshma",
"roles": [
"director",
"officer"
],
"title": "CEO \u0026 President"
}
],
"ownership": "D",
"post_shares": "143259",
"price": "483.75",
"row": 2,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "6554",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}Insider transactionsEvent date Feb 17, 2026
Grant, award or other acquisition by Kewalramani Reshma
- Security
- Common Stock
- Shares
-
16,326
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-02-17",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Restricted stock unit award that vests in installments beginning on February 20, 2027."
},
"owners": [
{
"cik": "0001735944",
"name": "Kewalramani Reshma",
"roles": [
"director",
"officer"
],
"title": "CEO \u0026 President"
}
],
"ownership": "D",
"post_shares": "149813",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "16326",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}